ZARVY

Distoside 600 contains 600mg of Praziquantel, a highly effective anthelmintic agent widely used in the treatment of trematode (flukes) and cestode (tapeworms) infections. Listed as a WHO essential medicine, it is considered indispensable in both clinical practice and mass deworming campaigns across endemic regions. Praziquantel demonstrates rapid absorption, excellent oral bioavailability, and high cure rates against a broad spectrum of parasitic flatworms. Its mechanism of action involves increasing calcium ion permeability in parasite cell membranes, leading to paralysis, detachment, and death of the worms. Distoside 600 remains a cornerstone therapy for conditions such as schistosomiasis, clonorchiasis, paragonimiasis, taeniasis, and neurocysticercosis, supporting global efforts in helminth control and eradication.

Billtree 600 contains 600mg of Praziquantel, a cornerstone antiparasitic medication listed as a WHO essential medicine. It is globally recognized for its efficacy against flatworm infections, targeting both trematodes (flukes) and cestodes (tapeworms). Its mechanism of action involves inducing intense spasms and paralysis in the worms’ musculature by altering calcium ion permeability. This results in the parasites detaching from host tissues, followed by their natural elimination from the body. Billtree 600 is widely employed in the treatment of schistosomiasis, liver fluke disease, tapeworm infections, and neurocysticercosis, and continues to play a central role in mass deworming campaigns and clinical practice worldwide.

Praziquantel 600mg is a broad-spectrum anthelmintic widely used for the treatment of parasitic worm infections. It demonstrates high efficacy against trematodes (flukes) and cestodes (tapeworms), and is internationally recognized as the standard therapy for schistosomiasis. Its mechanism of action involves increasing calcium ion permeability in the parasite’s membrane, which induces spastic paralysis, dislodgement, and eventual death of the parasite. Praziquantel is employed both in individual clinical treatment and in mass deworming programs across endemic regions, forming a cornerstone of global helminth control strategies.

Praziquin 600 contains Praziquantel 600mg per tablet, an oral antiparasitic treatment listed as a WHO essential medicine. It demonstrates potent efficacy against cestodes (tapeworms) and trematodes (flukes), making it a cornerstone therapy in parasitology. Praziquantel is widely used in the management of schistosomiasis, clonorchiasis, and neurocysticercosis, with proven effectiveness in both mass deworming campaigns and individual clinical settings. Its mechanism involves increasing the permeability of parasite cell membranes to calcium ions, resulting in spastic paralysis, dislodgement, and subsequent death of the parasite. Beyond its antiparasitic indications, praziquantel has also been explored in off-label contexts, including potential oncological adjunct therapy, where modulation of host–parasite interactions may support cancer research.